Nasal vaccination with attenuated Salmonella typhimurium strains expressing the Hepatitis B nucleocapsid: dose response analysis
- 26 March 2001
- Vol. 19 (20-22) , 2854-2861
- https://doi.org/10.1016/s0264-410x(01)00009-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Construction and Characterization of aSalmonella entericaSerovar Typhimurium Clone Expressing a Salivary Adhesin ofStreptococcus mutansunder Control of the Anaerobically InduciblenirBPromoterInfection and Immunity, 2000
- In Vivo Characterization of the Murine Intranasal Model for Assessing the Immunogenicity of AttenuatedSalmonella entericaSerovar Typhi Strains as Live Mucosal Vaccines and as Live VectorsInfection and Immunity, 2000
- Role of B cells in antigen presentation of the hepatitis B coreProceedings of the National Academy of Sciences, 1997
- A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigensVaccine, 1997
- Germinal Center Formation and Local Immunoglobulin E (IgE) Production in the Lung after an Airway Antigenic ChallengeThe Journal of Experimental Medicine, 1996
- Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectorsJournal of Biotechnology, 1996
- Avirulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccinationVaccine, 1993
- Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-γ-dominant versus an IL-4-dominant immune responseInternational Immunology, 1993
- Prospects for Oral Vaccination Using Recombinant Bacteria Expressing Viral EpitopesPublished by Elsevier ,1992
- A Contiguous Network of Dendritic Antigen-Presenting Cells within the Respiratory EpitheliumInternational Archives of Allergy and Immunology, 1990